Skip to content

Multicenter study of transcranial doppler in acute hepatic failure patients to predict encephalopathy onset

Multicentric Evaluation of Transcranial doppler to predict severe encephalopathy in Acute Liver Failure - METCALF

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/02/031428
Enrollment
64
Registered
2021-02-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K720- Acute and subacute hepatic failure Health Condition 2: T604- Toxic effect of rodenticides

Interventions

Intervention1: Nil: Nil

Sponsors

Amrita institute of medical sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having acute liver failure

Exclusion criteria

Exclusion criteria: Age less than 18 Hemodynamics instability

Design outcomes

Primary

MeasureTime frame
To evaluate the sensitivity of resistive index to predict onset of severe encephalopathy ( grade 3 or intubation ) by 48 hours in.adult acute liver failure patientsTimepoint: Daily , for 7 days

Secondary

MeasureTime frame
To evaluate the sensitivity of Resistive Index (RI) to predict onset of severe encephalopathy (Grade 3 or above, or intubation) by 72 hours in adult Acute Liver Failure (ALF) patientsTimepoint: 72 hours;. To evaluate the sensitivity of Pulsatility Index (PI) to predict onset of severe encephalopathy (Grade 3 or above, or intubation) by 72 hours in adult Acute Liver Failure (ALF) patients.Timepoint: 72 hours;To evaluate other indices like Pulsatility Index (PI) to predict onset of severe encephalopathy (Grade 3 or above, or intubation) by 48 hours in adult Acute Liver Failure (ALF) patients. Timepoint: 48 hours;To evaluate the correlation of arterial ammonia with degree of encephalopathyTimepoint: 72 hours;To evaluate the correlation of the RI, PI and arterial ammonia to grade of encephalopathy as the patient recovers, in those who recover either spontaneously or after liver transplantationTimepoint: NA

Countries

India

Contacts

Public ContactK SINDHUJA

Amrita institute of medical sciences

sindhuja.kayati@gmail.com7729927257

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026